Ryan Tedford to Follow-Up Studies
This is a "connection" page, showing publications Ryan Tedford has written about Follow-Up Studies.
Connection Strength
0.951
-
Less invasive surgical implant strategy and right heart failure after LVAD implantation. J Heart Lung Transplant. 2021 04; 40(4):289-297.
Score: 0.112
-
Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017 10 01; 2(10):1090-1099.
Score: 0.089
-
Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Heart Fail. 2017 Sep; 10(9).
Score: 0.089
-
Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population. Clin Transplant. 2015 Aug; 29(8):685-8.
Score: 0.076
-
The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail. 2015 Jan; 3(1):9-16.
Score: 0.073
-
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2012 Jan 17; 59(3):289-90.
Score: 0.060
-
Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2021 03 16; 10(6):e018127.
Score: 0.028
-
Exercise right ventricular ejection fraction predicts right ventricular contractile reserve. J Heart Lung Transplant. 2021 06; 40(6):504-512.
Score: 0.028
-
A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. J Card Fail. 2018 Jun; 24(6):384-391.
Score: 0.023
-
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2018 02 01; 197(3):388-391.
Score: 0.023
-
Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec 15; 120(12):2221-2225.
Score: 0.022
-
Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors. Int J Artif Organs. 2017 Oct 27; 40(11):622-628.
Score: 0.022
-
Usefulness of Pulse Amplitude Changes During the Valsalva Maneuver Measured Using Finger Photoplethysmography to Identify Elevated Pulmonary Capillary Wedge Pressure in Patients With Heart Failure. Am J Cardiol. 2017 Sep 15; 120(6):966-972.
Score: 0.022
-
Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function. Am J Cardiol. 2017 Jul 15; 120(2):274-278.
Score: 0.022
-
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. JAMA Cardiol. 2017 03 01; 2(3):293-302.
Score: 0.021
-
Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device. J Heart Lung Transplant. 2017 01; 36(1):97-105.
Score: 0.020
-
Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation. Ann Thorac Surg. 2016 Jul; 102(1):102-8.
Score: 0.020
-
Histamine H2 Receptor Antagonists, Left?Ventricular Morphology, and Heart?Failure?Risk: The MESA Study. J Am Coll Cardiol. 2016 Apr 05; 67(13):1544-1552.
Score: 0.020
-
Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction. Am J Cardiol. 2015 Nov 15; 116(10):1534-40.
Score: 0.019
-
Comparative Efficacy of Cardiac Resynchronization Therapy in Africans Americans Compared With European Americans. Am J Cardiol. 2015 Oct 01; 116(7):1101-5.
Score: 0.019
-
The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation. J Heart Lung Transplant. 2015 Nov; 34(11):1390-7.
Score: 0.019
-
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Jun; 8(3):437-46.
Score: 0.019
-
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015 Jan 15; 191(2):208-18.
Score: 0.019
-
Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads. Heart Rhythm. 2015 Mar; 12(3):517-523.
Score: 0.018
-
Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy. Am J Cardiol. 2015 Jan 01; 115(1):82-5.
Score: 0.018
-
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013 Oct 01; 62(14):1290-1297.
Score: 0.017
-
Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011 Nov; 38(11):2410-8.
Score: 0.015
-
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011 Sep 27; 58(14):1485-96.
Score: 0.015